Intuitive Surgical (NASDAQ:ISRG) Upgraded to Buy at Wall Street Zen

Intuitive Surgical (NASDAQ:ISRG) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

Several other equities research analysts have also recently commented on ISRG. Truist Financial increased their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday. Piper Sandler reaffirmed an “overweight” rating and set a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday. Royal Bank Of Canada increased their price objective on Intuitive Surgical from $605.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday. UBS Group increased their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research report on Wednesday. Finally, BTIG Research increased their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the company a “buy” rating in a research report on Wednesday. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $592.05.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $495.86 on Friday. Intuitive Surgical has a 1-year low of $425.00 and a 1-year high of $616.00. The business has a fifty day moving average price of $529.86 and a 200-day moving average price of $535.13. The company has a market capitalization of $177.73 billion, a PE ratio of 69.16, a PEG ratio of 5.45 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period last year, the company earned $1.78 earnings per share. The company’s revenue was up 21.4% on a year-over-year basis. On average, sell-side analysts anticipate that Intuitive Surgical will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director directly owned 6,371 shares in the company, valued at approximately $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 7,798 shares of company stock valued at $3,955,331 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several institutional investors and hedge funds have recently added to or reduced their stakes in ISRG. Brighton Jones LLC raised its stake in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the period. Bank Pictet & Cie Europe AG increased its stake in Intuitive Surgical by 0.5% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider’s stock worth $99,678,000 after acquiring an additional 883 shares during the last quarter. WINTON GROUP Ltd bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $1,021,000. New Age Alpha Advisors LLC bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $1,098,000. Finally, Orion Portfolio Solutions LLC increased its stake in Intuitive Surgical by 1.6% in the 4th quarter. Orion Portfolio Solutions LLC now owns 13,059 shares of the medical equipment provider’s stock worth $6,816,000 after acquiring an additional 204 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.